Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 4/2019

Ausgabe 4/2019

Inhaltsverzeichnis ( 16 Artikel )

18.03.2019 | Editorial | Ausgabe 4/2019

MDSC and beyond: a symposium-in-writing on myeloid cells with immunoregulatory activity by members of the Mye-EUNITER network

Sven Brandau

17.01.2019 | Original Article | Ausgabe 4/2019

Strong antigen-specific T-cell immunity induced by a recombinant human TERT measles virus vaccine and amplified by a DNA/viral vector prime boost in IFNAR/CD46 mice

Elodie Pliquet, Claude Ruffie, Marie Escande, Jessie Thalmensi, Valérie Najburg, Chantal Combredet, Thomas Bestetti, Marion Julithe, Christelle Liard, Thierry Huet, Simon Wain-Hobson, Frédéric Tangy, Pierre Langlade-Demoyen

19.01.2019 | Original Article | Ausgabe 4/2019

Adverse events need for hospitalization and systemic immunosuppression in very elderly patients (over 80 years) treated with ipilimumab for metastatic melanoma

Vaianu Leroy, Emilie Gerard, Caroline Dutriaux, Sorilla Prey, Aurelia Gey, Cécile Mertens, Marie Beylot-Barry, Anne Pham-Ledard

21.01.2019 | Original Article | Ausgabe 4/2019

Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma

Hamzah Abu-Sbeih, Faisal S. Ali, Wei Qiao, Yang Lu, Sapna Patel, Adi Diab, Yinghong Wang

22.01.2019 | Original Article | Ausgabe 4/2019

Prognostic value of tumour-infiltrating CD8+ lymphocytes in rectal cancer after neoadjuvant chemoradiation: is indoleamine-2,3-dioxygenase (IDO1) a friend or foe?

Julia Schollbach, Stefan Kircher, Armin Wiegering, Florian Seyfried, Ingo Klein, Andreas Rosenwald, Christoph-Thomas Germer, Stefan Löb

23.01.2019 | Original Article | Ausgabe 4/2019

A potential role for peripheral natural killer cell activity induced by preoperative chemotherapy in breast cancer patients

Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Yuri Funaoka, Naomi Yasuda, Masayuki Hidaka, Yukitaka Morita, Shoichro Ohtani, Mitsuya Ito, Koji Arihiro

06.02.2019 | Original Article | Ausgabe 4/2019 Open Access

Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics

Anna Felberg, Aleksandra Urban, Anna Borowska, Grzegorz Stasiłojć, Michał Taszner, Andrzej Hellmann, Anna Maria Blom, Marcin Okrój

28.01.2019 | Clinical Trial Report | Ausgabe 4/2019

The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma

David Agdashian, Mei ElGindi, Changqing Xie, Milan Sandhu, Drew Pratt, David E. Kleiner, William D. Figg, Julie A. Rytlewski, Catherine Sanders, Erik C. Yusko, Bradford Wood, David Venzon, Gagandeep Brar, Austin G. Duffy, Tim F. Greten, Firouzeh Korangy

05.02.2019 | Clinical Trial Report | Ausgabe 4/2019 Open Access

Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma

Sandra P. D’Angelo, Matthias Hunger, Andrew S. Brohl, Paul Nghiem, Shailender Bhatia, Omid Hamid, Janice M. Mehnert, Patrick Terheyden, Kent C. Shih, Isaac Brownell, Céleste Lebbé, Karl D. Lewis, Gerald P. Linette, Michele Milella, Michael Schlichting, Meliessa H. Hennessy, Murtuza Bharmal

06.02.2019 | Clinical Trial Report | Ausgabe 4/2019 Open Access

A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma

Lorena P. Suarez-Kelly, Kala M. Levine, Thomas E. Olencki, Sara E. Martin del Campo, Elizabeth A. Streacker, Taylor R. Brooks, Volodymyr I. Karpa, Joseph Markowitz, Anissa K. Bingman, Susan M. Geyer, Kari L. Kendra, William E. Carson

21.05.2018 | Symposium-in-Writing Paper | Ausgabe 4/2019

How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions

Annika M. Bruger, Anca Dorhoi, Gunes Esendagli, Katarzyna Barczyk-Kahlert, Pierre van der Bruggen, Marie Lipoldova, Tomas Perecko, Juan Santibanez, Margarida Saraiva, Jo A. Van Ginderachter, Sven Brandau

12.07.2018 | Symposium-in-Writing Paper | Ausgabe 4/2019

Interactions among myeloid regulatory cells in cancer

Viktor Umansky, Gosse J. Adema, Jaroslaw Baran, Sven Brandau, Jo A. Van Ginderachter, Xiaoying Hu, Jadwiga Jablonska, Slavko Mojsilovic, Helen A. Papadaki, Yago Pico de Coaña, Kim C. M. Santegoets, Juan F. Santibanez, Karine Serre, Yu Si, Isabela Sieminska, Maria Velegraki, Zvi G. Fridlender

24.10.2018 | Symposium-in-Writing Paper | Ausgabe 4/2019 Open Access

Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation

Giada Amodio, Joanna Cichy, Patricia Conde, Gianluca Matteoli, Aurélie Moreau, Jordi Ochando, Barbaros H. Oral, Michaela Pekarova, Elizabeth J. Ryan, Johannes Roth, Yahya Sohrabi, Maria-Cristina Cuturi, Silvia Gregori

19.12.2018 | Symposium-in-Writing Paper | Ausgabe 4/2019

MDSCs in infectious diseases: regulation, roles, and readjustment

Anca Dorhoi, Estibaliz Glaría, Thalia Garcia-Tellez, Natalie E. Nieuwenhuizen, Gennadiy Zelinskyy, Benoit Favier, Anurag Singh, Jan Ehrchen, Cornelia Gujer, Christian Münz, Margarida Saraiva, Yahya Sohrabi, Ana E. Sousa, Peter Delputte, Michaela Müller-Trutwin, Annabel F. Valledor

25.01.2019 | Symposium-in-Writing Paper | Ausgabe 4/2019 Open Access

Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates

Luca Cassetta, Espen S. Baekkevold, Sven Brandau, Anna Bujko, Marco A. Cassatella, Anca Dorhoi, Carsten Krieg, Ang Lin, Karin Loré, Olivia Marini, Jeffrey W. Pollard, Mikael Roussel, Patrizia Scapini, Viktor Umansky, Gosse J. Adema

15.03.2019 | ACKNOWLEDGEMENT TO REVIEWERS | Ausgabe 4/2019

Acknowledgements

Aktuelle Ausgaben


 

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise